Keita Shibuya

Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells

Keita Shibuya, Masashi Okada, Shuhei Suzuki et al. · Oncotarget · 2014 · 196 citations · Full text

Medicine, Cancer Biology, Oncology +17

Glioma-Initiating Cell Elimination by Metformin Activation of FOXO3 via AMPK

Atsushi Sato, Jun Sunayama, Masashi Okada et al. · Stem Cells Translational Medicine · 2012 · 184 citations · Full text

Medicine, Cancer Biology, Oncology +17

Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells

Atsushi Sato, Masashi Okada, Keita Shibuya et al. · Stem Cell Research · 2013 · 153 citations · Full text

Medicine, Cell Biology, Oncology +16

Targeting JNK for therapeutic depletion of stem-like glioblastoma cells

Kenichiro Matsuda, Atsushi Satō, Masashi Okada et al. · Scientific Reports · 2012 · 95 citations · Full text

Medicine, Cancer Biology, Oncology +17

JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells

Shuhei Suzuki, Masashi Okada, Keita Shibuya et al. · Oncotarget · 2014 · 94 citations · Full text

Medicine, Cancer Biology, Oncology +17